Medtronic Announces FDA Approval Of CGMS(R) IPRO(TM) continual Glucose Recorder

January 31st, 2008 | Category: Diabetes

Medtronic, Inc. (NYSE: MDT) announced the FDA approval of a new physician-use continual glucose monitoring (CGM) system, the CGMS® iPro™ Recorder. Physicians send patients home with the CGMS iPro Recorder to uncover patterns and potential problems that often go undetected with today’s standard

glucose measurements like finger stick meters and HbA1c tests. The new CGMS iPro Recorder is smaller, lighter in weight and less duration consuming to use than previous CGMS recorders.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Medtronic Announces FDA Clearance Of New OneTouch(R) Ultralink(TM) Blood Glucose Meter
  • Medtronic Announces Sales Milestone Of One Million continual Glucose Monitoring Sensors Worldwide
  • Medtronic And Bayer Diabetes Care Announce Alliance To supply Blood Glucose Meter To Medtronic Patients Outside The United States
  • DexComTM Receives FDA Approval To Calibrate Its SEVENTM continual Glucose Monitoring System Using Any FDA Cleared Blood Glucose Meter
  • Echo Therapeutics Announces Positive Results From Symphony(TM) Transdermal continual Glucose Monitoring System Study At Tufts Medical Center

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.